Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : IPHYF save search
Innate Pharma Presents at AACR 2024 Preclinical Efficacy of Its Pre-IND Drug Candidate IPH45, a Novel Nectin-4 Antibody Drug Conjugate
Published: 2024-04-10 (Crawled : 09:00) - biospace.com/
SNYNF | $92.966 0.07% -2.18% 0
|
Health Technology
|
| O: -0.01%
H: 0.0%
C: 0.0%
SNY | $46.24 0.68% 0.63% 0
|
Health Technology
|
| O: -0.32%
H: 0.0%
C: 0.0%
IPHA | $2.42 -2.42% 3.88% 3K
|
Health Technology
|
| O: -3.85%
H: 1.2%
C: 0.8%
iph45 pharma drug candidate antibody preclinical
Innate Pharma Announces Its Participation in Upcoming April 2024 Investor Conference
Published: 2024-04-09 (Crawled : 09:00) - biospace.com/
SNYNF | $92.966 0.07% -2.18% 0
|
Health Technology
|
| O: 0.28%
H: 0.0%
C: 0.0%
SNY | $46.24 0.68% 0.63% 0
|
Health Technology
|
| O: -0.38%
H: 0.95%
C: 0.83%
IPHA | $2.42 -2.42% 3.88% 3K
|
Health Technology
|
| O: 2.57%
H: 1.81%
C: 1.81%
pharma conference
Innate Pharma Files Its 2023 Universal Registration Document (Document d’enregistrement Universel) and 2023 Annual Report on Form 20-F
Published: 2024-04-05 (Crawled : 11:00) - biospace.com/
SNYNF | $92.966 0.07% -2.18% 0
|
Health Technology
|
| O: -1.77%
H: 0.0%
C: -1.81%
SNY | $46.24 0.68% 0.63% 0
|
Health Technology
|
| O: -3.44%
H: 0.0%
C: 0.0%
IPHA | $2.42 -2.42% 3.88% 3K
|
Health Technology
|
| O: -0.4%
H: 0.0%
C: -5.22%
pharma report universal
Innate Pharma Reports Full Year 2023 Financial Results and Business Update
Published: 2024-03-21 (Crawled : 09:00) - biospace.com/
SNYNF | $92.966 0.07% -2.18% 0
|
Health Technology
|
| O: 0.14%
H: 0.24%
C: 0.24%
SNY | $46.24 0.68% 0.63% 0
|
Health Technology
|
| O: 0.3%
H: 0.0%
C: 0.0%
IPHA | $2.42 -2.42% 3.88% 3K
|
Health Technology
|
| O: -4.51%
H: 4.25%
C: 0.96%
pharma business year update financial results
Innate Pharma Announces Its Participation to Upcoming Investor Conference - March 19, 2024
Published: 2024-03-19 (Crawled : 08:00) - biospace.com/
SNYNF | $92.966 0.07% -2.18% 0
|
Health Technology
|
| O: -0.02%
H: 0.0%
C: 0.0%
SNY | $46.24 0.68% 0.63% 0
|
Health Technology
|
| O: -1.51%
H: 0.0%
C: 0.0%
IPHA | $2.42 -2.42% 3.88% 3K
|
Health Technology
|
| O: 0.84%
H: 4.56%
C: 0.83%
pharma conference
Innate Pharma Announces Conference Call and Webcast for Full Year 2023 Financial Results
Published: 2024-03-14 (Crawled : 09:00) - biospace.com/
SNY | $46.24 0.68% 0.63% 0
|
Health Technology
|
| O: 0.23%
H: 0.0%
C: 0.0%
IPHA | $2.42 -2.42% 3.88% 3K
|
Health Technology
|
| O: -2.4%
H: 3.69%
C: 3.28%
pharma conference year financial results
Innate Pharma: First Patient dosed in Phase 1/2 study of IPH6501 in relapsed /refractory B-Cell non-Hodgkin’s Lymphoma
Published: 2024-03-06 (Crawled : 12:00) - biospace.com/
SNYNF | $92.966 0.07% -2.18% 0
|
Health Technology
|
| O: 0.0%
H: 0.8%
C: 0.8%
SNY | $46.24 0.68% 0.63% 0
|
Health Technology
|
| O: -0.45%
H: 0.0%
C: 0.0%
IPHA | $2.42 -2.42% 3.88% 3K
|
Health Technology
|
| O: 0.78%
H: 1.93%
C: 0.97%
iph6501 first study
Innate Pharma to Present Nectin-4 Antibody Drug Conjugate IPH45 Preclinical Data at AACR 2024
Published: 2024-03-06 (Crawled : 11:00) - biospace.com/
SNYNF | $92.966 0.07% -2.18% 0
|
Health Technology
|
| O: 0.0%
H: 0.8%
C: 0.8%
SNY | $46.24 0.68% 0.63% 0
|
Health Technology
|
| O: -0.45%
H: 0.0%
C: 0.0%
IPHA | $2.42 -2.42% 3.88% 3K
|
Health Technology
|
| O: 0.78%
H: 1.93%
C: 0.97%
iph45 pharma drug antibody preclinical
Innate Pharma Announces Its Participation to Upcoming March 2024 Investor Conference
Published: 2024-02-21 (Crawled : 07:00) - biospace.com/
SNYNF | $92.966 0.07% -2.18% 0
|
Health Technology
|
| O: 1.7%
H: 0.0%
C: 0.0%
SNY | $46.24 0.68% 0.63% 0
|
Health Technology
|
| O: -0.57%
H: 0.0%
C: 0.0%
IPHA | $2.42 -2.42% 3.88% 3K
|
Health Technology
|
| O: -2.32%
H: 0.0%
C: 0.0%
pharma conference
Number of Shares and Voting Rights of Innate Pharma as of January 1, 2024
Published: 2024-01-12 (Crawled : 11:00) - biospace.com/
SNYNF | $92.966 0.07% -2.18% 0
|
Health Technology
|
| O: 0.71%
H: 0.0%
C: 0.0%
SNY | $46.24 0.68% 0.63% 0
|
Health Technology
|
| O: 0.06%
H: 0.0%
C: 0.0%
IPHA | $2.42 -2.42% 3.88% 3K
|
Health Technology
|
| O: 0.0%
H: 0.36%
C: 0.36%
pharma
Innate Pharma Strengthens Leadership and Appoints Two New Members to Its Executive Board
Published: 2024-01-04 (Crawled : 09:00) - biospace.com/
SNYNF | $92.966 0.07% -2.18% 0
|
Health Technology
|
| O: 1.62%
H: 0.0%
C: 0.0%
SNY | $46.24 0.68% 0.63% 0
|
Health Technology
|
| O: 1.12%
H: 0.93%
C: 0.77%
IPHA | $2.42 -2.42% 3.88% 3K
|
Health Technology
|
| O: 6.47%
H: 3.65%
C: -2.36%
pharma
Innate Pharma Announces U.S. FDA Lifts Partial Clinical Hold on Lacutamab Clinical Program
Published: 2024-01-04 (Crawled : 08:00) - biospace.com/
SNYNF | $92.966 0.07% -2.18% 0
|
Health Technology
|
| O: 1.62%
H: 0.0%
C: 0.0%
SNY | $46.24 0.68% 0.63% 0
|
Health Technology
|
| O: 1.12%
H: 0.93%
C: 0.77%
IPHA | $2.42 -2.42% 3.88% 3K
|
Health Technology
|
| O: 6.47%
H: 3.65%
C: -2.36%
fda pharma program
Innate Pharma Announces Licensing of a Fourth Natural Killer Cell Engager in Oncology to Sanofi
Published: 2023-12-19 (Crawled : 08:00) - biospace.com/
NVO | $123.9 -0.49% -0.69% 20K
|
Health Technology
|
| O: 0.91%
H: 0.72%
C: 0.11%
SNY | $46.24 0.68% 0.63% 0
|
Health Technology
|
| O: 0.45%
H: 0.0%
C: 0.0%
IPHA | $2.42 -2.42% 3.88% 3K
|
Health Technology
|
| O: 13.88%
H: 0.0%
C: -3.58%
pharma natural cell sanofi
Innate Pharma Announces Leadership Change - December 18, 2023
Published: 2023-12-18 (Crawled : 10:00) - biospace.com/
SNY | $46.24 0.68% 0.63% 0
|
Health Technology
|
| O: 1.25%
H: 0.0%
C: 0.0%
IPHA | $2.42 -2.42% 3.88% 3K
|
Health Technology
|
| O: 2.9%
H: 2.02%
C: -1.21%
pharma change
Innate Pharma Shares Efficacy and Safety Phase 1 /2 Results of NK Cell Engager SAR443579 / IPH6101 Developed by Sanofi at ASH 2023
Published: 2023-12-11 (Crawled : 08:00) - biospace.com/
IPHYF | $2.65 104.6% 300
|
Health Technology
|
| O: 9.45%
H: 0.0%
C: -1.7%
SNYNF | $92.966 0.07% -2.18% 0
|
Health Technology
|
| O: 0.5%
H: 1.67%
C: 0.1%
SNY | $46.24 0.68% 0.63% 0
|
Health Technology
|
| O: 2.15%
H: 0.0%
C: 0.0%
IPHA | $2.42 -2.42% 3.88% 3K
|
Health Technology
|
| O: -1.16%
H: 0.39%
C: -4.31%
sar4435 pharma iph6101 cell results sanofi
Innate Pharma to Host Virtual KOL Event on Lacutamab
Published: 2023-11-27 (Crawled : 11:00) - biospace.com/
SNYNF | $92.966 0.07% -2.18% 0
|
Health Technology
|
| O: -0.36%
H: 0.0%
C: 0.0%
SNY | $46.24 0.68% 0.63% 0
|
Health Technology
|
| O: 1.04%
H: 0.17%
C: 0.11%
IPHA | $2.42 -2.42% 3.88% 3K
|
Health Technology
|
| O: 2.07%
H: 1.21%
C: 1.21%
pharma
Innate Pharma Reports Third Quarter 2023 Financial Results and Business Update
Published: 2023-11-14 (Crawled : 09:00) - biospace.com/
SNY | $46.24 0.68% 0.63% 0
|
Health Technology
|
| O: 0.68%
H: 0.0%
C: 0.0%
IPHA | $2.42 -2.42% 3.88% 3K
|
Health Technology
|
| O: 6.61%
H: 9.39%
C: 6.61%
pharma business update financial results
Innate Pharma Announces Conference Call for Third Quarter 2023 Business Update
Published: 2023-11-07 (Crawled : 08:00) - biospace.com/
SNY | $46.24 0.68% 0.63% 0
|
Health Technology
|
| O: -1.32%
H: 0.0%
C: 0.0%
IPHA | $2.42 -2.42% 3.88% 3K
|
Health Technology
|
| O: -2.31%
H: 2.76%
C: 1.18%
pharma conference business update
Innate Pharma Announces Its Participation to Upcoming November 2023 Investor Conferences
Published: 2023-10-27 (Crawled : 08:00) - biospace.com/
SNYNF | $92.966 0.07% -2.18% 0
|
Health Technology
|
| O: -18.18%
H: 0.0%
C: 0.0%
SNY | $46.24 0.68% 0.63% 0
|
Health Technology
|
| O: -15.73%
H: 0.0%
C: 0.0%
IPHA | $2.42 -2.42% 3.88% 3K
|
Health Technology
|
| O: -2.85%
H: 12.13%
C: 3.77%
pharma
Innate Pharma 2024 Financial Calendar
Published: 2023-10-19 (Crawled : 07:00) - biospace.com/
SNY | $46.24 0.68% 0.63% 0
|
Health Technology
|
| O: -2.42%
H: 0.0%
C: 0.0%
IPHA | $2.42 -2.42% 3.88% 3K
|
Health Technology
|
| O: -8.78%
H: 15.06%
C: 0.0%
pharma financial
Gainers vs Losers
| 28% | 72% |
Top 10 Gainers
AMPL | $9.83 2.08% 2.7K
|
CL | $86.445 0.32% 43K
|
Consumer Non-Durables
AESI | $22.105 0.11% 4.7K
|
n/a
EXPE 4 | $128.72 0.05% 18K
|
Consumer Services
AJG | $232.2 0.05% 11K
|
Finance
BCAB | $2.86 3.6K
|
DTE | $105.365 -0.15% 5.1K
|
Utilities
AME | $178.705 -0.19% 9.1K
|
Producer Manufacturing
ESTC 4 | $94.65 -0.21% 9.2K
|
Technology Services
EXC 4 | $36.19 -0.22% 48K
|
Utilities
Your saved searches
Save your searches and get alerts when important news are released.